SteinCares Opens New São Paulo Office, Strengthening Its Expansion in Brazil

  • The new office reinforces SteinCares’ presence in Latin America’s largest pharmaceutical market.
  • Designed to support continued growth, the new workspace promotes collaboration, agility, and operational excellence across the company’s expanding team in Brazil.

SÃO PAULO, Brazil, October 2026 – SteinCares, a specialty healthcare company with more than 45 years of experience across Latin America, officially inaugurated its new office in Brazil. The new headquarters marks the company’s continued investment and growing presence in the region’s largest pharmaceutical market. Held on October 27, the official opening was attended by Isaac Waserstein, the company’s founder, and Mitchell Waserstein, CEO of SteinCares, alongside officials, industry representatives, and the company’s entire team of employees.

Located in the HD 873 Corporate building in Chácara Santo Antônio, São Paulo (SP), the 385-square-meter space was strategically designed to accommodate a rapidly growing team, which currently numbers around 35 employees in the country. With capacity for nearly 50 workstations, the workplace was structured around the concept of smart zoning: an open, business-unit-based layout that eliminates physical barriers. The goal is to integrate teams operating in synergy, fostering spontaneous collaboration, high performance, and flexibility.

“This office represents a long-term commitment to Brazil. Here, we have built a home for a team dedicated to expanding access to high-complexity therapies for Brazilian patients, serving as a bridge between global innovation and the unmet needs of patients and the country’s healthcare system,” stated Julio Avella, General Manager for Brazil and LATAM Head for Rare Diseases.

With more than 45 years of history in Latin America, SteinCares officially launched its operations in Brazil in 2023 and is structured around three strategic focus areas: onco-hematology, immunology, and rare diseases. The company partners with global pharmaceutical and biotechnology firms to help broaden access to innovative therapies in areas of high unmet medical needs. Through its integrated platform, the organization combines regulatory, market access, supply chain, and commercial capabilities, connecting global pharmaceutical innovation to the needs of Brazilian patients and healthcare systems.

About SteinCares

SteinCares is a specialty healthcare company with more than 45 years of experience in the Latin American healthcare market and a presence in over 30 countries across the region. The company acts as a strategic bridge between leading global pharmaceutical and biotechnology companies and the region’s healthcare needs. Through its integrated, one-stop-shop platform, diversified portfolio, and highly experienced team, SteinCares works to expand access to innovative, safe, and cost-effective treatments, creating healthcare opportunities for patients throughout Latin America.

For more information, please visit http://www.steincares.com/ or follow the company on LinkedIn.